332 related articles for article (PubMed ID: 19306528)
1. Lecithin: cholesterol acyltransferase--from biochemistry to role in cardiovascular disease.
Rousset X; Vaisman B; Amar M; Sethi AA; Remaley AT
Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):163-71. PubMed ID: 19306528
[TBL] [Abstract][Full Text] [Related]
2. Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?
Kunnen S; Van Eck M
J Lipid Res; 2012 Sep; 53(9):1783-99. PubMed ID: 22566575
[TBL] [Abstract][Full Text] [Related]
3. Lecithin:cholesterol acyltransferase, high-density lipoproteins, and atheroprotection in humans.
Calabresi L; Franceschini G
Trends Cardiovasc Med; 2010 Feb; 20(2):50-3. PubMed ID: 20656215
[TBL] [Abstract][Full Text] [Related]
4. Role of LCAT in Atherosclerosis.
Ossoli A; Simonelli S; Vitali C; Franceschini G; Calabresi L
J Atheroscler Thromb; 2016; 23(2):119-27. PubMed ID: 26607351
[TBL] [Abstract][Full Text] [Related]
5. Adenoviral expression of human lecithin-cholesterol acyltransferase in nonhuman primates leads to an antiatherogenic lipoprotein phenotype by increasing high-density lipoprotein and lowering low-density lipoprotein.
Amar MJ; Shamburek RD; Vaisman B; Knapper CL; Foger B; Hoyt RF; Santamarina-Fojo S; Brewer HB; Remaley AT
Metabolism; 2009 Apr; 58(4):568-75. PubMed ID: 19303980
[TBL] [Abstract][Full Text] [Related]
6. The role of lecithin:cholesterol acyltransferase in the modulation of cardiometabolic risks - a clinical update and emerging insights from animal models.
Ng DS
Biochim Biophys Acta; 2012 Apr; 1821(4):654-9. PubMed ID: 22326749
[TBL] [Abstract][Full Text] [Related]
7. LCAT- targeted therapies: Progress, failures and future.
Yang K; Wang J; Xiang H; Ding P; Wu T; Ji G
Biomed Pharmacother; 2022 Mar; 147():112677. PubMed ID: 35121343
[TBL] [Abstract][Full Text] [Related]
8. A review on lecithin:cholesterol acyltransferase deficiency.
Saeedi R; Li M; Frohlich J
Clin Biochem; 2015 May; 48(7-8):472-5. PubMed ID: 25172171
[TBL] [Abstract][Full Text] [Related]
9. Lecithin cholesterol acyltransferase: an anti- or pro-atherogenic factor?
Rousset X; Shamburek R; Vaisman B; Amar M; Remaley AT
Curr Atheroscler Rep; 2011 Jun; 13(3):249-56. PubMed ID: 21331766
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous Atherosclerosis in Aged LCAT-Deficient Hamsters With Enhanced Oxidative Stress-Brief Report.
Guo M; Liu Z; Xu Y; Ma P; Huang W; Gao M; Wang Y; Liu G; Xian X
Arterioscler Thromb Vasc Biol; 2020 Dec; 40(12):2829-2836. PubMed ID: 32998519
[TBL] [Abstract][Full Text] [Related]
11. Complete and Partial Lecithin:Cholesterol Acyltransferase Deficiency Is Differentially Associated With Atherosclerosis.
Oldoni F; Baldassarre D; Castelnuovo S; Ossoli A; Amato M; van Capelleveen J; Hovingh GK; De Groot E; Bochem A; Simonelli S; Barbieri S; Veglia F; Franceschini G; Kuivenhoven JA; Holleboom AG; Calabresi L
Circulation; 2018 Sep; 138(10):1000-1007. PubMed ID: 29748187
[TBL] [Abstract][Full Text] [Related]
12. Very low levels of HDL cholesterol and atherosclerosis, a variable relationship--a review of LCAT deficiency.
Savel J; Lafitte M; Pucheu Y; Pradeau V; Tabarin A; Couffinhal T
Vasc Health Risk Manag; 2012; 8():357-61. PubMed ID: 22701329
[TBL] [Abstract][Full Text] [Related]
13. Novel lecithin: cholesterol acyltransferase-based therapeutic approaches.
Freeman LA; Karathanasis SK; Remaley AT
Curr Opin Lipidol; 2020 Apr; 31(2):71-79. PubMed ID: 32073411
[TBL] [Abstract][Full Text] [Related]
14. Advances in understanding of the role of lecithin cholesterol acyltransferase (LCAT) in cholesterol transport.
Dobiásová M; Frohlich JJ
Clin Chim Acta; 1999 Aug; 286(1-2):257-71. PubMed ID: 10511297
[TBL] [Abstract][Full Text] [Related]
15. Lecithin:cholesterol acyltransferase deficiency increases atherosclerosis in the low density lipoprotein receptor and apolipoprotein E knockout mice.
Furbee JW; Sawyer JK; Parks JS
J Biol Chem; 2002 Feb; 277(5):3511-9. PubMed ID: 11719520
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis.
Hoeg JM; Santamarina-Fojo S; Bérard AM; Cornhill JF; Herderick EE; Feldman SH; Haudenschild CC; Vaisman BL; Hoyt RF; Demosky SJ; Kauffman RD; Hazel CM; Marcovina SM; Brewer HB
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11448-53. PubMed ID: 8876155
[TBL] [Abstract][Full Text] [Related]
17. Lecithin cholesterol acyltransferase.
Jonas A
Biochim Biophys Acta; 2000 Dec; 1529(1-3):245-56. PubMed ID: 11111093
[TBL] [Abstract][Full Text] [Related]
18. Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humans.
Calabresi L; Baldassarre D; Castelnuovo S; Conca P; Bocchi L; Candini C; Frigerio B; Amato M; Sirtori CR; Alessandrini P; Arca M; Boscutti G; Cattin L; Gesualdo L; Sampietro T; Vaudo G; Veglia F; Calandra S; Franceschini G
Circulation; 2009 Aug; 120(7):628-35. PubMed ID: 19687369
[TBL] [Abstract][Full Text] [Related]
19. Lecithin-cholesterol acyltransferase: role in lipoprotein metabolism, reverse cholesterol transport and atherosclerosis.
Santamarina-Fojo S; Lambert G; Hoeg JM; Brewer HB
Curr Opin Lipidol; 2000 Jun; 11(3):267-75. PubMed ID: 10882342
[TBL] [Abstract][Full Text] [Related]
20. Recombinant lecithin:cholesterol acyltransferase containing a Thr123-->Ile mutation esterifies cholesterol in low density lipoprotein but not in high density lipoprotein.
O K; Hill JS; Wang X; Pritchard PH
J Lipid Res; 1993 Jan; 34(1):81-8. PubMed ID: 8445345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
